4.7 Article

FASN Is a Biomarker Enriched in Malignant Glioma-Derived Extracellular Vesicles

Journal

Publisher

MDPI
DOI: 10.3390/ijms21061931

Keywords

glioblastoma; astrocytoma; extracellular vesicles; exosomes; imaging flow cytometry; biomarker

Funding

  1. Anni Hofmann Stiftung
  2. Deutsche Forschungsgemeinschaft
  3. Johannes-Bauer Stiftung
  4. National Cancer Institute [P01CA069246]

Ask authors/readers for more resources

Extracellular vesicles (EVs) are known for their important role in cancer progression and hold considerable potential as a source for tumor biomarkers. However, purification of tumor-specific EVs from patient plasma is still an urgent unmet need due to contamination by normal host cell-derived EVs, that results in compromised analytical sensitivity. Here we identified fatty acid synthase (FASN), a key lipogenic enzyme which is highly expressed in malignant glioma cells, to be elevated in CD63- and CD81-positive EVs in glioma patient plasma samples, opening vital opportunities to sort brain tumor-specific EVs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available